Corporate$NBIX4:05 PM ETdeveloping · v2

Neurocrine Biosciences appoints Eiry W. Roberts as Chief Medical Officer, Sanjay Keswani departs

By BORSA NewsroomPublished Sep 28, 2026, 4:05 PM EDTUpdated Sep 28, 2026, 4:05 PM EDT

Eiry W. Roberts returns as CMO effective immediately, replacing Sanjay Keswani who leaves by mutual agreement. Roberts previously served as CMO from 2018-2025 and led key development programs including INGREZZA expansion and the crinecerfont program that led to CRENESSITY approval.

Sentimentneutral 50

Neutral · 50 of 100

Impact30

low · stays off the top drivers

Confidence95%

high confidence · 2 wires

Eventdeveloping

v2 · alerted to followers

WHAT WE KNOW

Eiry W. Roberts appointed CMO effective Sept. 28, 2026